AI blood test could spot lung cancer years earlier

NCT ID NCT07458425

Recruiting now Diagnosis Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing whether an artificial intelligence (AI) blood test and risk model can help find lung cancer early in people at high risk. Researchers will enroll 400 adults aged 50-80 who smoke or recently quit. Some will get the AI blood test, others an AI analysis of their CT scan. The goal is to see if these tools encourage more people to get screened and improve early detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial Intelligence (AI) blood test and risk model
What this could lead to: If successful, this could make lung cancer screening easier and more accurate, catching cancers earlier when they are more treatable.
What could go wrong: This is an early study with only 400 people at one center. The AI tool is still research-use-only for some participants, and it may not improve screening rates or detect cancers reliably.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

University of Illinois at Chicago
RECRUITING

Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.